-
1
-
-
14944385553
-
Global cancer statistics, 2002
-
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108. (Pubitemid 40372904)
-
(2005)
Ca-A Cancer Journal for Clinicians
, vol.55
, Issue.2
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
Pisani, P.4
-
3
-
-
33750379420
-
Polycomb silencers control cell fate, development and cancer
-
DOI 10.1038/nrc1991, PII NRC1991
-
Sparmann A, van Lohuizen M. Polycomb silencers control cell fate, development and cancer. Nat Rev Cancer 2006;6:846-56. (Pubitemid 44629896)
-
(2006)
Nature Reviews Cancer
, vol.6
, Issue.11
, pp. 846-856
-
-
Sparmann, A.1
Van Lohuizen, M.2
-
4
-
-
55949136562
-
Roles of the EZH2 histone methyltransferase in cancer epigenetics
-
Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res 2008;647:21-9.
-
(2008)
Mutat Res
, vol.647
, pp. 21-29
-
-
Simon, J.A.1
Lange, C.A.2
-
5
-
-
0141816752
-
EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells
-
DOI 10.1073/pnas.1933744100
-
Kleer CG, Cao Q, Varambally S, et al. EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells. Proc Natl Acad Sci U S A. 2003;100:11606-11. (Pubitemid 37205983)
-
(2003)
Proceedings of the National Academy of Sciences of the United States of America
, vol.100
, Issue.20
, pp. 11606-11611
-
-
Kleer, C.G.1
Cao, Q.2
Varambally, S.3
Shen, R.4
Ota, I.5
Tomlins, S.A.6
Ghosh, D.7
Sewalt, R.G.A.B.8
Otte, A.P.9
Hayes, D.F.10
Sabel, M.S.11
Livant, D.12
Weiss, S.J.13
Rubin, M.A.14
Chinnaiyan, A.M.15
-
6
-
-
34250706864
-
Polycomb-Group Oncogenes EZH2, BMI1, and RING1 Are Overexpressed in Prostate Cancer With Adverse Pathologic and Clinical Features
-
DOI 10.1016/j.eururo.2006.11.020, PII S0302283806013996
-
van Leenders GJ, Dukers D, Hessels D, et al. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features. Eur Urol 2007; 52:455-63. (Pubitemid 46963432)
-
(2007)
European Urology
, vol.52
, Issue.2
, pp. 455-463
-
-
Van Leenders, G.J.L.H.1
Dukers, D.2
Hessels, D.3
Van Den Kieboom, S.W.M.4
Hulsbergen, C.A.5
Witjes, J.A.6
Otte, A.P.7
Meijer, C.J.8
Raaphorst, F.M.9
-
7
-
-
19944403215
-
Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis
-
DOI 10.1593/neo.04160
-
Breuer RH, Snijders PJ, Smit EF, et al. Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis. Neoplasia 2004;6:736-43. (Pubitemid 40041491)
-
(2004)
Neoplasia
, vol.6
, Issue.6
, pp. 736-743
-
-
Breuer, R.H.J.1
Snijders, P.J.F.2
Smit, E.F.3
Sutedja, T.G.4
Sewalt, R.G.A.B.5
Otte, A.P.6
Van Kemenade, F.J.7
Postmus, P.E.8
Meijer, C.J.L.M.9
Raaphorst, F.M.10
-
8
-
-
76149136889
-
Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and metastasis in gastric cancer
-
Choi JH, Song YS, Yoon JS, et al. Enhancer of zeste homolog 2 expression is associated with tumor cell proliferation and metastasis in gastric cancer. APMIS 2010;118:196-202.
-
(2010)
APMIS
, vol.118
, pp. 196-202
-
-
Choi, J.H.1
Song, Y.S.2
Yoon, J.S.3
-
9
-
-
29344445843
-
Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder
-
DOI 10.1158/1078-0432.CCR-05-1047
-
Raman JD, Mongan NP, Tickoo SK, et al. Increased expression of the polycomb group gene, EZH2, in transitional cell carcinoma of the bladder. Clin Cancer Res 2005;11:8570-6. (Pubitemid 43005902)
-
(2005)
Clinical Cancer Research
, vol.11
, Issue.24
, pp. 8570-8576
-
-
Raman, J.D.1
Mongan, N.P.2
Tickoo, S.K.3
Boorjian, S.A.4
Scherr, D.S.5
Gudas, L.J.6
-
10
-
-
0035050744
-
The Polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma
-
DOI 10.1046/j.1365-2141.2001.02641.x
-
Visser HP, Gunster MJ, Kluin-Nelemans HC, et al. The polycomb group protein EZH2 is upregulated in proliferating, cultured human mantle cell lymphoma. Br J Haematol 2001;112:950-8. (Pubitemid 32322920)
-
(2001)
British Journal of Haematology
, vol.112
, Issue.4
, pp. 950-958
-
-
Visser, H.P.J.1
Gunster, M.J.2
Kluin-Nelemans, H.C.3
Manders, E.M.M.4
Raaphorst, F.M.5
Meijer, C.J.L.M.6
Willemze, R.7
Otte, A.P.8
-
11
-
-
57149107384
-
Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein
-
Holland D, Hoppe-Seyler K, Schuller B, et al. Activation of the enhancer of zeste homologue 2 gene by the human papillomavirus E7 oncoprotein. Cancer Res 2008;68:9964-72.
-
(2008)
Cancer Res
, vol.68
, pp. 9964-9972
-
-
Holland, D.1
Hoppe-Seyler, K.2
Schuller, B.3
-
12
-
-
0142105414
-
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer
-
DOI 10.1093/emboj/cdg542
-
Bracken AP, Pasini D, Capra M, et al. EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer. EMBO J 2003;22:5323-35. (Pubitemid 37279943)
-
(2003)
EMBO Journal
, vol.22
, Issue.20
, pp. 5323-5335
-
-
Bracken, A.P.1
Pasini, D.2
Capra, M.3
Prosperini, E.4
Colli, E.5
Helin, K.6
-
13
-
-
0035877978
-
Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma
-
van Kemenade FJ, Raaphorst FM, Blokzijl T, et al. Coexpression of BMI-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma. Blood 2001;97:3896-901.
-
(2001)
Blood
, vol.97
, pp. 3896-3901
-
-
Van Kemenade, F.J.1
Raaphorst, F.M.2
Blokzijl, T.3
-
14
-
-
33744519651
-
Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer
-
DOI 10.1111/j.1349-7006.2006.00203.x
-
Matsukawa Y, Semba S, Kato H, et al. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer. Cancer Sci 2006;97:484-91. (Pubitemid 43811589)
-
(2006)
Cancer Science
, vol.97
, Issue.6
, pp. 484-491
-
-
Matsukawa, Y.1
Semba, S.2
Kato, H.3
Ito, A.4
Yanagihara, K.5
Yokozaki, H.6
-
15
-
-
33644822360
-
EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast
-
DOI 10.1200/JCO.2005.01.5180
-
Bachmann IM, Halvorsen OJ, Collett K, et al. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast. J Clin Oncol 2006;24:268-73. (Pubitemid 46622055)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.2
, pp. 268-273
-
-
Bachmann, I.M.1
Halvorsen, O.J.2
Collett, K.3
Stefansson, I.M.4
Straume, O.5
Haukaas, S.A.6
Salvesen, H.B.7
Otte, A.P.8
Akslen, L.A.9
-
16
-
-
29344439946
-
Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas
-
Weikert S, Christoph F, Köllermann J, et al. Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas. Int J Mol Med 2005;16: 349-53.
-
(2005)
Int J Mol Med
, vol.16
, pp. 349-353
-
-
Weikert, S.1
Christoph, F.2
Köllermann, J.3
-
17
-
-
77953444201
-
High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy
-
He LR, Liu MZ, Li BK, et al. High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy. Int J Cancer 2010;127:138-47.
-
(2010)
Int J Cancer
, vol.127
, pp. 138-147
-
-
He, L.R.1
Liu, M.Z.2
Li, B.K.3
-
18
-
-
63049106529
-
Regulating post-translational modifications of the eukaryotic replication clamp PCN.A
-
Ulrich HD. Regulating post-translational modifications of the eukaryotic replication clamp PCNA. DNA Repair (Amst) 2009;8:461-9.
-
(2009)
DNA Repair (Amst)
, vol.8
, pp. 461-469
-
-
Ulrich, H.D.1
-
19
-
-
67649424560
-
P21 in cancer: Intricate networks and multiple activities
-
Abbas T, Dutta A. p21 in cancer: Intricate networks and multiple activities. Nat Rev Cancer 2009;9:400-14.
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 400-414
-
-
Abbas, T.1
Dutta, A.2
-
20
-
-
33646576168
-
Degradomics: Systems biology of the protease web. Pleiotropic roles of MMPs in cancer
-
DOI 10.1007/s10555-006-7890-0, Metalloproteinases and Cancer
-
Overall CM, Dean RA. Degradomics: Systems biology of the protease web. Pleiotropic roles of MMPs in cancer. Cancer Metastasis Rev 2006;25:69-75. (Pubitemid 43723983)
-
(2006)
Cancer and Metastasis Reviews
, vol.25
, Issue.1
, pp. 69-75
-
-
Overall, C.M.1
Dean, R.A.2
|